Cargando…
Phosphatidylcholine-Based Nanoemulsions for Paclitaxel and a P-Glycoprotein Inhibitor Delivery and Breast Cancer Intraductal Treatment
In this study, incorporation of the cytotoxic agent paclitaxel and the P-glycoprotein inhibitor elacridar in hyaluronic acid (HA)-modified nanoemulsions was studied for intraductal delivery and breast cancer localized treatment. To improve cytotoxicity, we investigated the incorporation of perillyl...
Autores principales: | Salata, Giovanna Cassone, Lopes, Luciana B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503599/ https://www.ncbi.nlm.nih.gov/pubmed/36145331 http://dx.doi.org/10.3390/ph15091110 |
Ejemplares similares
-
Multifunctional nanoemulsions for intraductal delivery as a new platform for local treatment of breast cancer
por: Migotto, Amanda, et al.
Publicado: (2018) -
Soy Protein Isolate-Phosphatidylcholine Nanoemulsions Prepared Using High-Pressure Homogenization
por: Li, Yang, et al.
Publicado: (2018) -
Effect of ultrasonication on the stability and storage of a soy protein isolate-phosphatidylcholine nanoemulsions
por: Teng, Fei, et al.
Publicado: (2020) -
A Multifunctional Polymeric Micelle for Targeted Delivery of Paclitaxel by the Inhibition of the P-Glycoprotein Transporters
por: Razzaq, Sobia, et al.
Publicado: (2021) -
Solid-Nanoemulsion Preconcentrate for Oral Delivery of Paclitaxel: Formulation Design, Biodistribution, and γ Scintigraphy Imaging
por: Ahmad, Javed, et al.
Publicado: (2014)